| |
|
|
|
Amneal Pharmaceuticals Inc  
|
|
4.35 0.11 (0.03%) |
09-22 16:00 |
|
Open: |
4.27 |
Pre close: |
4.24 |
Target:
|
5.23
|
|
High: |
4.46 |
Low: |
4.24 |
Resistance:
|
4.48
5.23
|
|
Volume: |
1,367,428 |
Market Cap: |
642M |
Support:
|
3.84
3.45
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.32
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
4.00 |
Signal(12,26,9): |
-0.07 |
|
MA(100): |
4.41 |
Stochastic Oscillator |
%K(14,3):
|
88.03  |
|
MA(250): |
4.02 |
%D(3): |
88.93 |
|
Average Volume(K) |
3-Month: |
114161
|
52-Week |
High:
|
5.79 |
|
10-Days: |
102241 |
Low: |
2.40 |
|
RSI |
RSI(14):
|
56.36 |
Change(%): |
28.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.371 |
Return on Equity (ttm) |
-58.4 |
Shares Out. (M) |
147.54 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
1.8 |
Shares Float (M) |
94.30 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.36 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
14.8 |
% Held by Institutions |
69.44 |
|
Forward EPS |
-2.740 |
Gross Profit (p.s.) |
3.368 |
Shares Short (K) |
6910 |
|
Book Value (p.s.) |
2.080 |
EBITDA (p.s.) |
2.325 |
P/E |
-3.17 |
|
Sales Per Share |
11.793 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.09 |
|
Profit Margin |
-11.16 |
Operating Cash Flow
(M) |
317.29 |
P/S |
0.37 |
|
Operating Margin |
6.85 |
Levered Free Cash Flow
(M) |
212.67 |
P/CF |
2.02 |
|
|
|
|
|
|
